1. De novo mTOR inhibitor‐based immunosuppression in ABO‐incompatible kidney transplantation. (5th October 2015) Authors: Koch, Martina; Wiech, Thorsten; Marget, Matthias; Peine, Sven; Thude, Hansjörg; Achilles, Eike G.; Fischer, Lutz; Lehnhardt, Anja; Thaiss, Friedrich; Nashan, Bjoern Journal: Clinical transplantation Issue: Volume 29:Number 11(2015) Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II–Restricted, Hepatitis Delta Virus (HDV)–Specific T-Cell Responses Regardless of Clinical Status. (23rd September 2018) Authors: Landahl, Johanna; Bockmann, Jan Hendrik; Scheurich, Christoph; Ackermann, Christin; Matzat, Verena; Heide, Janna; Nuurei, Tungalag; D'Antonio, Gianluca; von Felden, Johann; Sette, Alessandro; Peine, Sven; Lohse, Ansgar W; Luetgehetmann, Marc; Marget, Matthias; Sidney, John; Schulze zur Wiesch, Ju... Journal: Journal of infectious diseases Issue: Volume 219:Number 4(2019) Page Start: 568 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Differential virus‐specific CD8+ T‐cell epitope repertoire in hepatitis C virus genotype 1 versus 4. Issue 7 (27th February 2018) Authors: Luxenburger, Hendrik; Graß, Franziska; Baermann, Janina; Boettler, Tobias; Marget, Matthias; Emmerich, Florian; Panning, Marcus; Thimme, Robert; Nitschke, Katja; Neumann‐Haefelin, Christoph Journal: Journal of viral hepatitis Issue: Volume 25:Issue 7(2018) Page Start: 779 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. High B‐cell activating factor is not associated with worse 3‐year graft outcome in blood group‐incompatible kidney transplantation with rituximab induction. (18th February 2015) Authors: Lehnhardt, Anja M.; Strecker, Maximiliane; Eiermann, Thomas; Marget, Matthias; Thaiss, Friedrich; Nashan, Björn; Koch, Martina Journal: Clinical transplantation Issue: Volume 29:Number 4(2015) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Presence of donor specific HLA class 2 antibodies (DSA class 2) is associated with development of graft fibrosis more than 10 years after liver transplantation–a retrospective single center study. Issue 7 (18th May 2021) Authors: Sultani, Bejan; Marget, Matthias; Briem‐Richter, Andrea; Herrmann, Jochen; Meisner, Sebastian; Grabhorn, Enke Freya; Ozga, Ann‐Kathrin; Weidemann, Sören; Herden, Uta; Fischer, Lutz; Sterneck, Martina Journal: Clinical transplantation Issue: Volume 35:Issue 7(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Protein tyrosine phosphatase non‐receptor type 22 (PTPN22) gene polymorphisms in liver transplant donors and impact on acute cellular liver transplant rejection. (9th December 2019) Authors: Thude, Hansjörg; Tiede, Petra; Marget, Matthias; Peine, Sven; Nashan, Björn; Koch, Martina Journal: HLA Issue: Volume 95:Number 1(2020) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗